Integrating chemokine signatures and multi-omic biomarkers to predict immunotherapy response in non-small cell lung cancer: a comprehensive narrative review - Top-Institutions - MDSpire

Integrating chemokine signatures and multi-omic biomarkers to predict immunotherapy response in non-small cell lung cancer: a comprehensive narrative review

  • By

  • Luis Cabezón-Gutiérrez

  • Magda Palka-Kotlowska

  • Sara Custodio-Cabello

  • Adriana Carolina Rosero-Rodriguez

  • Beatriz Chacón-Ovejero

  • July 2, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Oncology

  • #2

    Gustave Roussy
    Gustave Roussy

    Villejuif, France

    Key Differentiators

    • Oncology

  • #3

    Mayo Clinic
    Mayo Clinic

    Rochester, Minnesota

    Key Differentiators

    • Oncology

  • #4

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, Maryland

    Key Differentiators

    • Oncology

  • #5

    Stanford University
    Stanford University

    Stanford, California

    Key Differentiators

    • Oncology

Original Source(s)

Integrating chemokine signatures and multi-omic biomarkers to predict immunotherapy response in non-small cell lung cancer: a comprehensive narrative review

  • by Luis Cabezón-Gutiérrez, Magda Palka-Kotlowska, Sara Custodio-Cabello, Adriana Carolina Rosero-Rodriguez, Beatriz Chacón-Ovejero

  • July 2, 2026

Related Content

New AI-Enabled Technology Supports Radiology Follow-Up Throughout Baptist Health

Baptist Health Herbert Wertheim Cancer Institute has launched Eon, an AI-enabled software platform that analyzes radiology reports and helps identify and prioritize incidental findings for clinical review, in an effort to support timely, coordinated patient care.

  • by

  • July 1, 2026

  • 2 min
Microbiome dysbiosis and its modulation in cancer development, prevention and therapy

Incidental thyroid carcinoma in surgically treated multinodular goiter: a retrospective study